Nuveen Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $259K | Hold |
515,445
| – | – | ﹤0.01% | 3157 |
|
|
2024
Q3 | $467K | Hold |
515,445
| – | – | ﹤0.01% | 3038 |
|
|
2024
Q2 | $514K | Hold |
515,445
| – | – | ﹤0.01% | 2983 |
|
|
2024
Q1 | $763K | Hold |
515,445
| – | – | ﹤0.01% | 2810 |
|
|
2023
Q4 | $562K | Hold |
515,445
| – | – | ﹤0.01% | 2968 |
|
|
2023
Q3 | $608K | Hold |
515,445
| – | – | ﹤0.01% | 2778 |
|
|
2023
Q2 | $727K | Buy |
+515,445
| New | +$727K | ﹤0.01% | 2789 |
|
|
2022
Q2 | – | Sell |
-551,993
| Closed | -$750K | – | 3333 |
|
|
2022
Q1 | $750K | Buy |
551,993
+145,063
| +36% | +$197K | ﹤0.01% | 2906 |
|
|
2021
Q4 | $745K | Sell |
406,930
-34,661
| -8% | -$63.5K | ﹤0.01% | 2955 |
|
|
2021
Q3 | $1.13M | Sell |
441,591
-8,320
| -2% | -$21.2K | ﹤0.01% | 2952 |
|
|
2021
Q2 | $1.28M | Buy |
+449,911
| New | +$1.28M | ﹤0.01% | 2913 |
|
|
2020
Q2 | – | Sell |
-423,265
| Closed | -$350K | – | 3238 |
|
|
2020
Q1 | $350K | Sell |
423,265
-66,546
| -14% | -$55K | ﹤0.01% | 2889 |
|
|
2019
Q4 | $435K | Sell |
489,811
-580,940
| -54% | -$516K | ﹤0.01% | 2936 |
|
|
2019
Q3 | $1.05M | Buy |
1,070,751
+72,602
| +7% | +$71.1K | ﹤0.01% | 2686 |
|
|
2019
Q2 | $1.1M | Buy |
+998,149
| New | +$1.1M | ﹤0.01% | 2695 |
|